4//SEC Filing
CHEN YINLIN JACK 4
Accession 0001593968-23-001182
CIK 0001737287other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 7:59 PM ET
Size
6.7 KB
Accession
0001593968-23-001182
Insider Transaction Report
Form 4
CHEN YINLIN JACK
SVP, Finance
Transactions
- Award
Common Stock
2023-08-10+11,401→ 88,881 total - Award
Stock Option (Right to Buy)
2023-08-10+39,160→ 39,160 totalExercise: $4.21Exp: 2033-08-10→ Common Stock (39,160 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option shall vest on August 10, 2024, and the remaining shares shall vest in 36 equal monthly installments thereafter.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001989926
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 7:59 PM ET
- Size
- 6.7 KB